Literature DB >> 19795447

Altered molecular pathways in melanocytic lesions.

Maria Scatolini1, Maurizia Mello Grand1, Enrico Grosso1, Tiziana Venesio2, Alberto Pisacane2, Antonella Balsamo2, Roberta Sirovich3, Mauro Risio2, Giovanna Chiorino1.   

Abstract

To identify gene expression changes in melanocytic lesions, biopsies from 18 common nevi (CMN), 11 dysplastic nevi (DN), 8 radial and 15 vertical growth phase melanomas (RGPM, VGPM), and 5 melanoma metastases (MTS) were analyzed using whole genome microarrays. The comparison between CMN and RGPM showed an enrichment of Gene Ontology terms related to inter and intracellular junctions, whereas the transition from RGPM to VGPM underlined the alteration of apoptosis. Upregulation of genes involved in dsDNA break repair and downregulation of cellular adhesion genes were observed in MTS with respect to VGPM. DN exhibited rather heterogeneous molecular profiles, with some proliferation genes expressed at higher levels than in CMN, altered regulation of transcription compared to RGPM and a subset of processes, such as mismatch repair, equally expressed as in VGPM. Furthermore, the expression profile of genes involved into cellular detoxification and antigen presentation split them into two classes, with different proliferation potential. Finally, molecular profiling of individual lesions identified altered biological processes, such as regulation of apoptosis, regulation of transcription and T-cell activation, not associated with specific histological classes but rather with subgroups of samples without apparent relationship. This holds true for dysplastic nevi in particular. Our data indicate that generally the intersection between stage specific and sample specific molecular alterations may lead to a more precise determination of the individual progression risk of melanocytic lesions.

Entities:  

Mesh:

Year:  2010        PMID: 19795447     DOI: 10.1002/ijc.24899

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  32 in total

1.  Cell cycle analysis can differentiate thin melanomas from dysplastic nevi and reveals accelerated replication in thick melanomas.

Authors:  Gergo Kiszner; Barnabas Wichmann; Istvan B Nemeth; Erika Varga; Nora Meggyeshazi; Ivett Teleki; Peter Balla; Mate E Maros; Karoly Penksza; Tibor Krenacs
Journal:  Virchows Arch       Date:  2014-03-30       Impact factor: 4.064

Review 2.  Predicting the outcome of melanoma: can we tell the future of a patient's melanoma?

Authors:  Oriol Yélamos; Pedram Gerami
Journal:  Melanoma Manag       Date:  2015-08-10

3.  A PGC1α-mediated transcriptional axis suppresses melanoma metastasis.

Authors:  Chi Luo; Ji-Hong Lim; Yoonjin Lee; Scott R Granter; Ajith Thomas; Francisca Vazquez; Hans R Widlund; Pere Puigserver
Journal:  Nature       Date:  2016-08-31       Impact factor: 49.962

4.  Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression.

Authors:  Amy E Rose; Laura Poliseno; Jinhua Wang; Michael Clark; Alexander Pearlman; Guimin Wang; Eleazar C Vega Y Saenz de Miera; Ratna Medicherla; Paul J Christos; Richard Shapiro; Anna Pavlick; Farbod Darvishian; Jiri Zavadil; David Polsky; Eva Hernando; Harry Ostrer; Iman Osman
Journal:  Cancer Res       Date:  2011-02-22       Impact factor: 12.701

5.  Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells.

Authors:  Najla El-Hachem; Nadia Habel; Tanesha Naiken; Hanene Bzioueche; Yann Cheli; Guillaume E Beranger; Emilie Jaune; Florian Rouaud; Nicolas Nottet; Frédéric Reinier; Céline Gaudel; Pascale Colosetti; Corine Bertolotto; Robert Ballotti
Journal:  Cell Death Differ       Date:  2018-03-07       Impact factor: 15.828

6.  Use of gene expression and pathway signatures to characterize the complexity of human melanoma.

Authors:  Jennifer A Freedman; Douglas S Tyler; Joseph R Nevins; Christina K Augustine
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

7.  The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management.

Authors:  Keith Duffy; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2012-07       Impact factor: 11.527

Review 8.  Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.

Authors:  Holly S Greenwald; Erica B Friedman; Iman Osman
Journal:  Melanoma Res       Date:  2012-02       Impact factor: 3.599

9.  MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway.

Authors:  Radoslav Janostiak; Navin Rauniyar; TuKiet T Lam; Jianhong Ou; Lihua J Zhu; Michael R Green; Narendra Wajapeyee
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

Review 10.  Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule.

Authors:  Antonella Chillemi; Gianluca Zaccarello; Valeria Quarona; Manuela Ferracin; Chiara Ghimenti; Massimo Massaia; Alberto L Horenstein; Fabio Malavasi
Journal:  Mol Med       Date:  2013-05-20       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.